RYTHM Inc

Análisis de la acción RYTHM Inc (RYM)

$15.590

-0.633 (-4.06%)Al cierre

Loading chart…
Máximo
16.816
Apertura
16.510
Precio medio ponderado por volumen
16.00
Volumen
5.14K
Capitalización
—
Mínimo
15.590
Importe
82.20K
EV/EBITDA, TTM
0.00

RYTHM, Inc., formerly Agrify Corporation, is a provider of branded innovative solutions for the cannabis and hemp industries. The Company’s portfolio of brands includes RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, & Shine, Doctor Solomon’s and Good Green in thousands of physical locations and online channels. The Company’s portfolio of consumer-packaged goods brands includes Senorita brand which offers consumers hemp-derived tetrahydrocannabinol (THC) beverages that mirror well-known cocktails like a margarita in four flavors, including classic Lime JalapeNo Margarita, Mango Margarita, Paloma and Ranch Water. Senorita offers a low-sugar, low-calorie alternative to alcoholic beverages and is available at retailers, including Total Wine, ABC Fine Wine & Spirits, and Binny’s in 11 U.S. states and Canada. Its comprehensive extraction product line includes hydrocarbon, alcohol, solventless, post-processing, and lab equipment.

rythm.com

Análisis de IA of RYTHM Inc (RYM)

Mantener

Agrify Corp (RYM) is currently priced at $16.20, which is significantly below its 52-week high of $50.38, indicating potential upside. However, the RSI is at 39.276, suggesting the stock is nearing oversold territory but not yet a strong buy signal. The forward P/E ratio is 0, indicating uncertainty in future earnings, and the gross margin is improving at 80.52% in Q2 2026, which is a positive sign. The main risk is the recent performance, with a year-to-date change of -26.66% and a one-year change of -60.66%, indicating significant volatility and potential challenges ahead.

Métricas de valoración

El PER previsto actual de RYTHM Inc (RYM) es 0.00, frente a su media de 5 años de -0.06.

PER previsto

Muy sobrevalorado
Media 5A P/E
-0.06
P/E actual
0.00
Sobrevalorada
-0.04
Infravalorada
-0.08

EV/EBITDA previsto

Muy sobrevalorado
Media 5A EV/EBITDA
-9.69
EV/EBITDA actual
0.00
Sobrevalorada
-7.05
Infravalorada
-12.33

Precio/ventas previsto

Muy infravalorado
Media 5A P/S
0.68
P/S actual
0.00
Sobrevalorada
0.88
Infravalorada
0.48

Ballenas con RYM en cartera

A

Accident Compensation Corporation

+ Con en carteraRYM

+2.69%

Rentabilidad a 3 meses

Cronología de eventos

2026-05-08 (ET)

11:10:00

RYTHM Named Official THC Beverage Partner of Navy Pier

2026-04-01 (ET)

07:30:00

RYTHM Amends Trademark Agreement with Green Thumb, Annual Fee of $70M

2026-01-27 (ET)

07:20:00

Chicago's United Center Partners with Senorita and RYTHM for THC Beverages

2025-12-12 (ET)

09:50:00

RYTHM Inc Trading Resumes

09:40:00

RYTHM Inc Trading Halted Due to Volatility

Noticias

Preguntas frecuentes sobre RYM, respondidas por Alphio AI

RYTHM, Inc., formerly Agrify Corporation, is a provider of branded innovative solutions for the cannabis and hemp industries. The Company’s portfolio of brands includes RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, & Shine, Doctor Solomon’s and Good Green in thousands of physical locations and online channels. The Company’s portfolio of consumer-packaged goods brands includes Senorita brand which offers consumers hemp-derived tetrahydrocannabinol (THC) beverages that mirror well-known cocktails like a margarita in four flavors, including classic Lime JalapeNo Margarita, Mango Margarita, Paloma and Ranch Water. Senorita offers a low-sugar, low-calorie alternative to alcoholic beverages and is available at retailers, including Total Wine, ABC Fine Wine & Spirits, and Binny’s in 11 U.S. states and Canada. Its comprehensive extraction product line includes hydrocarbon, alcohol, solventless, post-processing, and lab equipment. It operates in the Consumer Non-Cyclicals sector.

Agrify Corp (RYM) is currently priced at $16.20, which is significantly below its 52-week high of $50.38, indicating potential upside. However, the RSI is at 39.276, suggesting the stock is nearing oversold territory but not yet a strong buy signal. The forward P/E ratio is 0, indicating uncertainty in future earnings, and the gross margin is improving at 80.52% in Q2 2026, which is a positive sign. The main risk is the recent performance, with a year-to-date change of -26.66% and a one-year change of -60.66%, indicating significant volatility and potential challenges ahead.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Artículos relacionados

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar